McQuivey originally joined Clinical Innovations in 2003, providing leadership in medical affairs and intelligence, clinical program development and medical safety and risk assessments. In his expanded role, McQuivey will also be responsible for supporting business acquisitions, new product innovation, advisory board oversight, product quality evaluations and clinical affairs.
“Ross brings nearly two decades of exemplary scientific, medical and business leadership in the medical device industry, with documented success developing creative and innovative solutions to thrive in untapped and highly competitive markets,” said Ken Reali, president/CEO of Clinical Innovations. “He’s been instrumental in developing the culture and growth strategy at Clinical Innovations and we’re proud of his continued role on our senior leadership team.”
McQuivey serves as an adjunct clinical instructor within the department of obstetrics and gynecology at the Stanford University School of Medicine (California) and has provided more than 150 international lectures and more than 200 domestic workshops advancing medical intelligence and training. He holds a bachelor’s degree in psychology from Stanford University and a doctorate of medicine from the University of Utah School of Medicine.
“I’m honored and humbled to serve with such dedicated, visionary colleagues, like Ken, who work tirelessly to improve care and outcomes for patients and families,” said McQuivey. “Never has there been a more transformative time in healthcare and I look forward to continuing to set the standard for excellence with the world-class Clinical Innovations team.”
Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. The Murray, Utah-based company has developed various products, including the Koala Intrauterine Pressure Catheter; Kiwi Vacuum-Assisted Delivery System; ROM Plus Rupture of Membranes Test; traxi Panniculus Retractor and ClearView Uterine Manipulator.Pritzker Group, led by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which provides early-stage and growth venture funding to technology companies throughout the United States; and Asset Management, which partners with top-performing investment managers across global public markets. Pritzker Group Private Capital acquires North America-based middle-market companies with leading positions in the manufactured products, services and healthcare sectors.